Status:
ACTIVE_NOT_RECRUITING
Adolescent and Young Adult Cancer Survivors: Identity Development
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Cancer
Eligibility:
All Genders
15-25 years
Brief Summary
The purpose of this study is to better understand how the illness has affected the identity and what needs the survivor may have. We hope that this information will help us provide better care to futu...
Eligibility Criteria
Inclusion
- Current age greater than and including 15 and up to and including 25 years of age at time of consent
- Diagnosis of a first cancer \> or = to 14 and up to and including 21 years of age
- At least 6 months post-treatment according to participant's self-report.
- Able to provide informed consent (or parent or legal guardian consent and participant assent for those participants under 18 years of age)
- Able to speak English. This inclusion criterion is included because study assessments were designed and validated in English and many of them are not currently available in other languages. Translation of questionnaires into other languages would require reestablishing the reliability and validity of these measures. Therefore, participants must be able to communicate in English to complete the assessments.
Exclusion
- Will exclude survivors with severe cognitive impairment that precludes them from being able to give information consent and/or complete the questionnaires.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00832325
Start Date
January 1 2009
End Date
January 1 2026
Last Update
January 8 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065